The EASL guidelines on the clinical management of hereditary cholestatic liver disease, published in 2024, suggest that genetic testing should be performed as early as possible in the diagnostic process after ruling out common causes. Along with a better understanding of the genes and proteins involved in biliary homeostasis and the increasing availability of genetic testing, more and more patients with adult-onset cholestasis are being tested for cholestasis genes that play a role in progressive intrahepatic familial cholestasis (PFIC).
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Postoperative cognitive dysfunction
Effects of midazolam and dexmedetomidine
- From symptom to diagnosis
Abdominal pain – groin pain: musculoskeletal causes
- Immunotherapy
Subcutaneously or intravenously?
- Cannabis - medical vs. non-medical use
Interim assessment: the boundaries are fluid
- Case Report
Cutaneous myiasis caused by botfly larvae
- Chronic insomnia, REM sleep instability and emotional dysregulation
Risk factors for anxiety and depression
- Immune sensors
Dysfunctional signaling pathways in cardiomyocytes and their role in heart disease
- Inoperable NSCLC